These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34311148)

  • 21. An interrupted time series evaluation of the effect of cannabis legalization on intentional self-harm in two Canadian provinces: Ontario and Alberta.
    Cusimano MD; Carpino M; Walker M; Saarela O; Mann R
    Health Promot Chronic Dis Prev Can; 2023 Sep; 43(9):403-408. PubMed ID: 37707352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between sales of legal medical cannabis and alcohol in Canada
    Armstrong MJ
    Health Policy; 2023 Feb; 128():28-33. PubMed ID: 36443110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada.
    Myran DT; Tanuseputro P; Auger N; Konikoff L; Talarico R; Finkelstein Y
    JAMA Health Forum; 2023 Jan; 4(1):e225041. PubMed ID: 36637814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
    Anderson KK; Rodrigues R; Le B; Mamun M; Archie S; Edwards J; Elton-Marshall T; Gilliland J; Myran DT; Palaniyappan L; Perlman CM; Seabrook JA; Murray RM; Shariff SZ
    Int J Drug Policy; 2024 Jan; 123():104285. PubMed ID: 38071933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019).
    Imtiaz S; Nigatu YT; Ali F; Douglas L; Hamilton HA; Rehm J; Rueda S; Schwartz RM; Wells S; Elton-Marshall T
    Drug Alcohol Depend; 2023 Mar; 244():109765. PubMed ID: 36652851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience.
    Rubin-Kahana DS; Crépault JF; Matheson J; Le Foll B
    Front Psychiatry; 2022; 13():984485. PubMed ID: 36213917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of marijuana purchase task based demand functions for optimal legal pricing of cannabis.
    Childs J; Poirier A
    Int J Drug Policy; 2021 Sep; 95():103271. PubMed ID: 34049233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada.
    Wiese JL; Watson TM; Owusu-Bempah A; Hyshka E; Wells S; Robinson M; Elton-Marshall T; Rueda S
    Contemp Drug Probl; 2023 Mar; 50(1):25-45. PubMed ID: 36733492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Legalization of cannabis in Canada-Local media analysis.
    Sorensen JL; van Draanen J; Shingle M
    Am J Addict; 2022 Mar; 31(2):148-151. PubMed ID: 35102629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis legalization with strict regulation, the overall superior policy option for public health.
    Rehm J; Fischer B
    Clin Pharmacol Ther; 2015 Jun; 97(6):541-4. PubMed ID: 25677377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Legalization of cannabis: A Swedish perspective].
    Bejerot S; Glans M
    Lakartidningen; 2021 Jan; 118():. PubMed ID: 33449354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps.
    Kilmer B
    Am J Drug Alcohol Abuse; 2019; 45(6):664-672. PubMed ID: 31264899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-medical cannabis use: international policies and outcomes overview. An outline for Portugal.
    Barata PC; Ferreira F; Oliveira C
    Trends Psychiatry Psychother; 2022 May; 44(Suppl 1):e20210239. PubMed ID: 34898143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Asbridge M; Stockwell T; Macdonald S; Peterman BH; Kish SJ
    Drug Alcohol Depend; 2021 Nov; 228():109008. PubMed ID: 34508959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Youth Cannabis use and Legalization in Canada - Reconsidering the Fears, Myths and Facts Three Years In.
    Haines-Saah RJ; Fischer B
    J Can Acad Child Adolesc Psychiatry; 2021 Aug; 30(3):191-196. PubMed ID: 34381511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A missed opportunity? Cannabis legalization and reparations in Canada.
    Valleriani J; Lavalley J; McNeil R
    Can J Public Health; 2018 Dec; 109(5-6):745-747. PubMed ID: 30225575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis Policy in the 21st Century: Mandating an Equitable Future and Shedding the Racist Past.
    Montgomery BW; Allen J
    Clin Ther; 2023 Jun; 45(6):541-550. PubMed ID: 37414505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CANNABIS LEGALIZATION IN STATE LEGISLATURES: PUBLIC HEALTH OPPORTUNITY AND RISK.
    Orenstein DG; Glantz SA
    Marquette Law Rev; 2020; 103(4):1313-1400. PubMed ID: 34376874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.